AD-RIDDLE

Happy second birthday to @ad-riddle.bsky.social! Visit their website to find out how this project is bridging the gap between research and precision medicine to prevent, detect and treat #AlzheimersDisease. #Health #Research #EU

02.02.2026 14:45 — 👍 2    🔁 1    💬 0    📌 0

🎉 AD-RIDDLE turns 2!

We celebrate the second anniversary of our AD-RIDDLE project, launched in January 2024, with the support of the EU's @ihieurope.bsky.social (IHI).

🌟Thank you to our incredible partners, researchers an supporters for making this possible!

➡️ For more info, visit: ad-riddle.org

30.01.2026 11:16 — 👍 1    🔁 0    💬 0    📌 1

Clinical translation of fluid, imaging, and digital biomarkers for Alzheimer’s disease - Alzheimer's Research & Therapy Alzheimer's Research & Therapy - Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting millions worldwide. The clinical presentation of AD is heterogenous...

🧠 Check out this review providing an overview of current clinical applications of fluid, imaging and digital biomarkers for Alzheimer’s disease.

@ad-riddle.bsky.social is mentioned as a recent effort to bridge the gap between translational & personalised medicine

link.springer.com/article/10.1...

20.01.2026 09:34 — 👍 1    🔁 2    💬 0    📌 0

📣 Our project co-lead Miia Kivipelto will be speaking in a plenary session “Information Systems for Dementia” at the upcoming Alzheimer's Disease International conference (14-16 April, Lyon)! #ADI2026

🗓️Today is the last day to register with the early bird rate ➡️ adiconference.org

15.01.2026 08:14 — 👍 2    🔁 1    💬 0    📌 0

📣Follow @access-ad.bsky.social, a new @ihieurope.bsky.social project, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.

👉 Visit the project's website for more information: access-ad.org

13.01.2026 12:19 — 👍 4    🔁 2    💬 0    📌 0

Enhancing diagnostic precision in Alzheimer's disease: Impact of comorbidities on blood biomarkers for clinical integration INTRODUCTION Comorbidities may influence Alzheimer's disease (AD) plasma biomarkers. This study aimed to investigate how medical conditions impact AD plasma biomarkers and whether comorbidity-adjust...

🚨NEW paper published in Alzheimer's & Dementia investigating the diagnostic accuracy and clinical utility of key Alzheimer's disease-related plasma biomarkers.

Congratulations to all authors👏
@ihieurope.bsky.social

Check it out⤵️

alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

13.01.2026 12:17 — 👍 3    🔁 2    💬 0    📌 0

A postbox covered in snow

Just published: the last IHI newsletter of 2025 👉 link.europa.eu/t4QV3R
💡 Get updates on our next call for proposals
📺 Catch up on our events on TB and regulatory impact
🚴 Discover how one project uses sport to build team spirit
🔬 Learn how our projects are contributing to cancer research
#HorizonEU

19.12.2025 10:28 — 👍 4    🔁 2    💬 0    📌 0